TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised, Double-blind, Active-controlled, Double-dummy, Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Cancer Pain
Brief Summary: The purpose of this study is to test the oxycodone/naloxone combination compared to oxycodone alone in patient's specific type of "chronic cancer pain".


Options:
A: Intervention Type: DRUG; Name: oxycodone fentanyl; Assigned to Arm(s): N/A
B: Arm Label: Morphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Morphine | Arm Label: Oxycodone; Type: EXPERIMENTAL; Interventions: Drug: Oxycodone | Arm Label: Buprenorphine; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine | Arm Label: Fentanyl; Type: EXPERIMENTAL; Interventions: Drug: Fentanyl | Intervention Type: DRUG; Name: Morphine; Assigned to Arm(s): Morphine | Intervention Type: DRUG; Name: Fentanyl; Assigned to Arm(s): Fentanyl | Intervention Type: DRUG; Name: Buprenorphine; Assigned to Arm(s): Buprenorphine | Intervention Type: DRUG; Name: Oxycodone; Assigned to Arm(s): Oxycodone
C: Arm Label: 001; Type: EXPERIMENTAL; Interventions: Drug: R331333 (referred to as JNS024 ER or CG5503) | Arm Label: 002; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxycodone CR | Intervention Type: DRUG; Name: Oxycodone CR; Assigned to Arm(s): 002 | Intervention Type: DRUG; Name: R331333 (referred to as JNS024 ER or CG5503); Assigned to Arm(s): 001
D: Arm Label: Oxycodone Hydrochloride Tablets; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxycodone | Arm Label: Oxycodone Naloxone Tablets; Type: EXPERIMENTAL; Interventions: Drug: Oxycodone/Naloxone | Intervention Type: DRUG; Name: Oxycodone; Assigned to Arm(s): Oxycodone Hydrochloride Tablets | Intervention Type: DRUG; Name: Oxycodone/Naloxone; Assigned to Arm(s): Oxycodone Naloxone Tablets

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Helping Alcoholics Link to Substance Abuse Treatment Programs After Being in the Hospital for Detoxification
Brief Summary: The purpose of this study is to determine whether peer visits (known as "12th Step Calls") and professional counselors (using "Motivational Enhancement Therapy") are effective helping alcoholics link to substance abuse treatment programs after being in the hospital for detox.


Options:
A: Arm Label: Treatment As Usual (TAU); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Motivational Enhancement Therapy (MET); Type: EXPERIMENTAL; Interventions: Behavioral: Motivation Enhancement Therapy (MET) | Arm Label: Peer-delivered Twelve Step Facilitation; Type: EXPERIMENTAL; Interventions: Behavioral: Peer-Twelve Step Facilitation (P-TSF) | Intervention Type: BEHAVIORAL; Name: Motivation Enhancement Therapy (MET); Assigned to Arm(s): Motivational Enhancement Therapy (MET) | Intervention Type: BEHAVIORAL; Name: Peer-Twelve Step Facilitation (P-TSF); Assigned to Arm(s): Peer-delivered Twelve Step Facilitation
B: Arm Label: motivational interviewing; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing, Other: Treatment as usual | Arm Label: control group; Type: OTHER; Interventions: Other: Treatment as usual | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): motivational interviewing | Intervention Type: OTHER; Name: Treatment as usual; Assigned to Arm(s): control group, motivational interviewing
C: Arm Label: No Intervention: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Motivational Interviewing; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): Motivational Interviewing
D: Arm Label: Usual Care; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: usual care | Arm Label: CHAT brief MI intervention; Type: EXPERIMENTAL; Interventions: Behavioral: CHAT brief MI intervention | Intervention Type: BEHAVIORAL; Name: CHAT brief MI intervention; Assigned to Arm(s): CHAT brief MI intervention | Intervention Type: BEHAVIORAL; Name: usual care; Assigned to Arm(s): Usual Care

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Helping Alcoholics Link to Substance Abuse Treatment Programs After Being in the Hospital for Detoxification
Brief Summary: The purpose of this study is to determine whether peer visits (known as "12th Step Calls") and professional counselors (using "Motivational Enhancement Therapy") are effective helping alcoholics link to substance abuse treatment programs after being in the hospital for detox.


Options:
A: Arm Label: Treatment As Usual (TAU); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Motivational Enhancement Therapy (MET); Type: EXPERIMENTAL; Interventions: Behavioral: Motivation Enhancement Therapy (MET) | Arm Label: Peer-delivered Twelve Step Facilitation; Type: EXPERIMENTAL; Interventions: Behavioral: Peer-Twelve Step Facilitation (P-TSF) | Intervention Type: BEHAVIORAL; Name: Motivation Enhancement Therapy (MET); Assigned to Arm(s): Motivational Enhancement Therapy (MET) | Intervention Type: BEHAVIORAL; Name: Peer-Twelve Step Facilitation (P-TSF); Assigned to Arm(s): Peer-delivered Twelve Step Facilitation
B: Arm Label: Introduction to AA volunteer; Type: OTHER; Interventions: Other: Introduction to AA volunteer | Arm Label: AA materials offered; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Introduction to AA volunteer; Assigned to Arm(s): Introduction to AA volunteer
C: Intervention Type: BEHAVIORAL; Name: Behavior Therapy; Assigned to Arm(s): N/A
D: Arm Label: Network Support; Type: EXPERIMENTAL; Interventions: Behavioral: Coping Skills Training | Arm Label: Packaged Cognitive-Behavioral Treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Coping Skills Training | Intervention Type: BEHAVIORAL; Name: Coping Skills Training; Assigned to Arm(s): Network Support, Packaged Cognitive-Behavioral Treatment

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Natural History of Community-Associated Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Infections and an Evaluation of Decolonization Strategies
Brief Summary: The purpose of this study is to determine the natural history of community-associated Staphylococcus aureus infections in both adult and pediatric patients by monitoring the rate of recurrent infections in those colonized with S. aureus.

In addition, this study will evaluate the efficiency of commonly prescribed decolonization measures in patients presenting with S. aureus skin and soft tissue infections.


Options:
A: Intervention Type: DRUG; Name: antimicrobial agent in soap; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: N/A; Interventions: N/A
C: Arm Label: Single-Dose IV Oritavancin Diphosphate; Type: EXPERIMENTAL; Interventions: Drug: Single-Dose IV Oritavancin Diphosphate, Drug: Placebo | Arm Label: IV Vancomycin; Type: ACTIVE_COMPARATOR; Interventions: Drug: IV Vancomycin | Intervention Type: DRUG; Name: Single-Dose IV Oritavancin Diphosphate; Assigned to Arm(s): Single-Dose IV Oritavancin Diphosphate | Intervention Type: DRUG; Name: IV Vancomycin; Assigned to Arm(s): IV Vancomycin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Single-Dose IV Oritavancin Diphosphate
D: Arm Label: 1: Hygiene Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intensive education on personal hygiene | Arm Label: 2: Hygiene education + mupirocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mupirocin ointment, Behavioral: Intensive education on personal hygiene | Arm Label: Education + mupirocin + chlorhexidine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mupirocin ointment, Genetic: Chlorhexidine showers, Behavioral: Intensive education on personal hygiene | Arm Label: 4: Education + mupirocin + bleach baths; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mupirocin ointment, Procedure: Bleach baths (dilute), Behavioral: Intensive education on personal hygiene | Intervention Type: DRUG; Name: Mupirocin ointment; Assigned to Arm(s): 2: Hygiene education + mupirocin, 4: Education + mupirocin + bleach baths, Education + mupirocin + chlorhexidine | Intervention Type: GENETIC; Name: Chlorhexidine showers; Assigned to Arm(s): Education + mupirocin + chlorhexidine | Intervention Type: PROCEDURE; Name: Bleach baths (dilute); Assigned to Arm(s): 4: Education + mupirocin + bleach baths | Intervention Type: BEHAVIORAL; Name: Intensive education on personal hygiene; Assigned to Arm(s): 1: Hygiene Education, 2: Hygiene education + mupirocin, 4: Education + mupirocin + bleach baths, Education + mupirocin + chlorhexidine

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Enhanced Continuity of Pharmacy Care for Cardiovascular or Pulmonary Diseases
Brief Summary: This study will test whether enhanced continuity of pharmacy care that includes increased communication between inpatient and outpatient settings will improve the appropriateness of medication therapy and reduce the number of serious adverse drug events, hospitalizations and unscheduled office visits in vulnerable patients with cardiovascular disease, pulmonary disease or diabetes.


Options:
A: Arm Label: Pre-intervention; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Mentored medication reconciliation quality improvement | Intervention Type: OTHER; Name: Mentored medication reconciliation quality improvement; Assigned to Arm(s): Intervention
B: Arm Label: Unrestricted; Type: ACTIVE_COMPARATOR; Interventions: Other: Unrestricted | Arm Label: Restricted; Type: ACTIVE_COMPARATOR; Interventions: Other: Restricted | Intervention Type: OTHER; Name: Unrestricted; Assigned to Arm(s): Unrestricted | Intervention Type: OTHER; Name: Restricted; Assigned to Arm(s): Restricted
C: Arm Label: Minimal intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Minimal intervention | Arm Label: Enhanced intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Minimal intervention; Assigned to Arm(s): Minimal intervention | Intervention Type: BEHAVIORAL; Name: Enhanced Intervention; Assigned to Arm(s): Enhanced intervention
D: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Pharmacist obtains home med hx; Type: EXPERIMENTAL; Interventions: Other: Pharmacist obtains admission medication history | Arm Label: Pharm tech obtains home med hx; Type: EXPERIMENTAL; Interventions: Other: Pharmacy technician obtains admission medication history | Intervention Type: OTHER; Name: Pharmacist obtains admission medication history; Assigned to Arm(s): Pharmacist obtains home med hx | Intervention Type: OTHER; Name: Pharmacy technician obtains admission medication history; Assigned to Arm(s): Pharm tech obtains home med hx

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Enhanced Continuity of Pharmacy Care for Cardiovascular or Pulmonary Diseases
Brief Summary: This study will test whether enhanced continuity of pharmacy care that includes increased communication between inpatient and outpatient settings will improve the appropriateness of medication therapy and reduce the number of serious adverse drug events, hospitalizations and unscheduled office visits in vulnerable patients with cardiovascular disease, pulmonary disease or diabetes.


Options:
A: Intervention Type: BEHAVIORAL; Name: Observation (behavior); Assigned to Arm(s): N/A
B: Arm Label: Pharmacist service,; Type: ACTIVE_COMPARATOR; Interventions: Other: Pharmacist service | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Pharmacist service; Assigned to Arm(s): Pharmacist service,
C: Arm Label: Minimal intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Minimal intervention | Arm Label: Enhanced intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Minimal intervention; Assigned to Arm(s): Minimal intervention | Intervention Type: BEHAVIORAL; Name: Enhanced Intervention; Assigned to Arm(s): Enhanced intervention
D: Arm Label: I; Type: EXPERIMENTAL; Interventions: Other: Drug review 80+ -To reduce usage of hospital care | Arm Label: C; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Drug review 80+ -To reduce usage of hospital care; Assigned to Arm(s): I

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Enhanced Continuity of Pharmacy Care for Cardiovascular or Pulmonary Diseases
Brief Summary: This study will test whether enhanced continuity of pharmacy care that includes increased communication between inpatient and outpatient settings will improve the appropriateness of medication therapy and reduce the number of serious adverse drug events, hospitalizations and unscheduled office visits in vulnerable patients with cardiovascular disease, pulmonary disease or diabetes.


Options:
A: Intervention Type: BEHAVIORAL; Name: Internet-based Dyspnea Self-Management Program; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Face-to-face Dyspnea Self-Management Program; Assigned to Arm(s): N/A
B: Arm Label: Pulmonary Rehabilitation Group; Type: EXPERIMENTAL; Interventions: Behavioral: Pulmonary Intervention | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Pulmonary Intervention; Assigned to Arm(s): Pulmonary Rehabilitation Group
C: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Ususal care | Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: RT management | Intervention Type: OTHER; Name: RT management; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Ususal care; Assigned to Arm(s): Control
D: Arm Label: Minimal intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Minimal intervention | Arm Label: Enhanced intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Minimal intervention; Assigned to Arm(s): Minimal intervention | Intervention Type: BEHAVIORAL; Name: Enhanced Intervention; Assigned to Arm(s): Enhanced intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Enhanced Continuity of Pharmacy Care for Cardiovascular or Pulmonary Diseases
Brief Summary: This study will test whether enhanced continuity of pharmacy care that includes increased communication between inpatient and outpatient settings will improve the appropriateness of medication therapy and reduce the number of serious adverse drug events, hospitalizations and unscheduled office visits in vulnerable patients with cardiovascular disease, pulmonary disease or diabetes.


Options:
A: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease | Intervention Type: BEHAVIORAL; Name: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease; Assigned to Arm(s): 2
B: Arm Label: Minimal intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Minimal intervention | Arm Label: Enhanced intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Minimal intervention; Assigned to Arm(s): Minimal intervention | Intervention Type: BEHAVIORAL; Name: Enhanced Intervention; Assigned to Arm(s): Enhanced intervention
C: Arm Label: TCM integrated group; Type: ACTIVE_COMPARATOR; Interventions: Other: acupuncture, massage and basic TCM treatment | Arm Label: Western Medicine group; Type: ACTIVE_COMPARATOR; Interventions: Other: rehabilitation and WM basic treatment | Intervention Type: OTHER; Name: acupuncture, massage and basic TCM treatment; Assigned to Arm(s): TCM integrated group | Intervention Type: OTHER; Name: rehabilitation and WM basic treatment; Assigned to Arm(s): Western Medicine group
D: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Link2Care; Type: EXPERIMENTAL; Interventions: Other: Link2Care | Intervention Type: OTHER; Name: Link2Care; Assigned to Arm(s): Link2Care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Enhanced Continuity of Pharmacy Care for Cardiovascular or Pulmonary Diseases
Brief Summary: This study will test whether enhanced continuity of pharmacy care that includes increased communication between inpatient and outpatient settings will improve the appropriateness of medication therapy and reduce the number of serious adverse drug events, hospitalizations and unscheduled office visits in vulnerable patients with cardiovascular disease, pulmonary disease or diabetes.


Options:
A: Arm Label: Minimal intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Minimal intervention | Arm Label: Enhanced intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Minimal intervention; Assigned to Arm(s): Minimal intervention | Intervention Type: BEHAVIORAL; Name: Enhanced Intervention; Assigned to Arm(s): Enhanced intervention
B: Arm Label: Pharmacist Intervention; Type: EXPERIMENTAL; Interventions: Procedure: Pharmacist Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Pharmacist Intervention; Assigned to Arm(s): Pharmacist Intervention
C: Intervention Type: BEHAVIORAL; Name: Pharmacist intervention; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Computer-Assisted Decision Support | Intervention Type: PROCEDURE; Name: Computer-Assisted Decision Support; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Enhanced Continuity of Pharmacy Care for Cardiovascular or Pulmonary Diseases
Brief Summary: This study will test whether enhanced continuity of pharmacy care that includes increased communication between inpatient and outpatient settings will improve the appropriateness of medication therapy and reduce the number of serious adverse drug events, hospitalizations and unscheduled office visits in vulnerable patients with cardiovascular disease, pulmonary disease or diabetes.


Options:
A: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Pharmacist intervention; Type: EXPERIMENTAL; Interventions: Behavioral: multidisciplinary treatment | Intervention Type: BEHAVIORAL; Name: multidisciplinary treatment; Assigned to Arm(s): Pharmacist intervention
B: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease | Intervention Type: BEHAVIORAL; Name: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease; Assigned to Arm(s): 2
C: Arm Label: Minimal intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Minimal intervention | Arm Label: Enhanced intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Minimal intervention; Assigned to Arm(s): Minimal intervention | Intervention Type: BEHAVIORAL; Name: Enhanced Intervention; Assigned to Arm(s): Enhanced intervention
D: Arm Label: Pharmacist Arm; Type: EXPERIMENTAL; Interventions: Behavioral: Pharmacist-led Hospital Discharge Care Intervention | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Pharmacist-led Hospital Discharge Care Intervention; Assigned to Arm(s): Pharmacist Arm

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Enhanced Continuity of Pharmacy Care for Cardiovascular or Pulmonary Diseases
Brief Summary: This study will test whether enhanced continuity of pharmacy care that includes increased communication between inpatient and outpatient settings will improve the appropriateness of medication therapy and reduce the number of serious adverse drug events, hospitalizations and unscheduled office visits in vulnerable patients with cardiovascular disease, pulmonary disease or diabetes.


Options:
A: Arm Label: Re-engineered hospital discharge; Type: EXPERIMENTAL; Interventions: Behavioral: Re-Engineered Hospital Discharge | Arm Label: Standard hospital discharge; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Re-Engineered Hospital Discharge; Assigned to Arm(s): Re-engineered hospital discharge
B: Arm Label: I; Type: EXPERIMENTAL; Interventions: Other: Drug review 80+ -To reduce usage of hospital care | Arm Label: C; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Drug review 80+ -To reduce usage of hospital care; Assigned to Arm(s): I
C: Arm Label: Minimal intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Minimal intervention | Arm Label: Enhanced intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Minimal intervention; Assigned to Arm(s): Minimal intervention | Intervention Type: BEHAVIORAL; Name: Enhanced Intervention; Assigned to Arm(s): Enhanced intervention
D: Arm Label: MI + IVR; Type: EXPERIMENTAL; Interventions: Behavioral: MI + IVR | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: MI + IVR; Assigned to Arm(s): MI + IVR

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Zinc as an Adjunct to Treatment of Pneumonia in Young Children
Brief Summary: The propose of this study is to evaluate if zinc given as an adjunct to standard treatment of severe pneumonia in young children shortens the duration and reduces treatment failure, and if these effects are pathogen-dependant.


Options:
A: Intervention Type: DRUG; Name: Vitamin + Zinc + micronutrient mixture; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Vitamin A; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Vitamin A + Zinc; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Children in the zinc group received 20 mg of elemental zinc as acetate per day in a twice-daily dose for two weeks.; Assigned to Arm(s): N/A
C: Arm Label: Zinc; Type: EXPERIMENTAL; Interventions: Drug: Zinc (zinc sulphate) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Zinc (zinc sulphate); Assigned to Arm(s): Zinc | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: X: Zinc sulphate; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Zinc sulphate | Intervention Type: DIETARY_SUPPLEMENT; Name: Zinc sulphate; Assigned to Arm(s): X: Zinc sulphate

Answer: D